Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

Medicines and Healthcare products Regulatory Agency (MHRA) – Statement regarding the new Clinical Trials Framework (from Catapult’s regulatory round-up for December 2024)

The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 were laid before Parliament on 12 December 2024. When approved by Parliament, this legislation will represent the most significant reform of UK clinical trials regulation in over 20 years, addressing the sector’s need for a more efficient and adaptable regulatory framework. The amended regulatory framework will aim to speed up trial approvals and encourage innovation in trial design without compromising patient safety.

The reforms will:

  • Create a proportionate and flexible regulatory environment
  • Cement the UK as a leading destination for international trials
  • Move away from a one-size-fits all approach, to be responsive to innovation
  • Ensure patients and their safety are at the focus of all clinical trials and supported by greater transparency bring the benefits of clinical trials to everyone

Please find the statement made by Baroness Merron Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health.

Published on the 9th of January 2025. Read the entire Regulatory Round-up – December 2024 (catapult.org.uk)


OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (12 février 2025). Medicines and Healthcare products Regulatory Agency (MHRA) – Statement regarding the new Clinical Trials Framework (from Catapult’s regulatory round-up for December 2024). ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/13axu


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.